AUSTRALIAN pharma company Echo Therapeutics has appointed Matthew Ryan to the newly created role of Head of Business Development.
With a clinical background as a registered nurse, Ryan brings more than 15 years of experience across the Australian health and pharmaceutical sectors.
Echo said the appointment marks a significant milestone in the company's growth and commitment to patient care across Australia and New Zealand, and reflects the company's ongoing investment in strategic leadership and innovation.
Echo works with healthcare professionals to apply legacy brands effectively in areas such as opioid stewardship, patient safety and therapeutic optimisation, delivering safer, smarter, and more sustainable care solutions.
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Nov 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Nov 25
